The Effect of Losartan in Preventing Paclitaxel-Induced Peripheral Neuropathy in Breast Cancer: A Randomized, Controlled Study.
Pharmacotherapy · Apr 1, 2026
What's New: Daily losartan was associated with significantly lower rates of paclitaxel-induced peripheral neuropathy in women with early-stage breast cancer.
Read more →